aica ribonucleotide has been researched along with Hypertrophy in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egawa, T; Goto, A; Goto, K; Ikuta, A; Ohira, T; Ohira, Y; Ohno, Y; Sugiura, T; Suzuki, M; Yokoyama, S; Yoshioka, T | 1 |
Bonafos, B; Bonnieu, A; Chabi, B; Coudray, C; Favier, FB; Feillet-Coudray, C; Fouret, G; Matecki, S; Pauly, M; Ramonatxo, C; Vanterpool, F; Vernus, B | 1 |
Böhm, M; Laufs, U; Lenski, M; Stuck, BJ | 1 |
Foretz, M; Lantier, L; Leclerc, J; Mounier, R; Sotiropoulos, A; Viollet, B | 1 |
Barton, ER; Birnbaum, MJ; Mu, J | 1 |
Chan, AY; Dyck, JR; Proud, CG; Soltys, CL; Young, ME | 1 |
Fick, CA; Gordon, SE; Thomson, DM | 1 |
1 review(s) available for aica ribonucleotide and Hypertrophy
Article | Year |
---|---|
Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Enzyme Inhibitors; Glycogen; Glycogen Synthase; Hypertrophy; Hypoxia; Mice; Multienzyme Complexes; Muscle, Skeletal; Mutation; Phenotype; Physical Conditioning, Animal; Protein Serine-Threonine Kinases; Ribonucleotides; Time Factors; Transcription, Genetic | 2003 |
6 other study(ies) available for aica ribonucleotide and Hypertrophy
Article | Year |
---|---|
AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Enzyme Activation; HSP72 Heat-Shock Proteins; Hypertrophy; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Proteolysis; Ribonucleotides; RNA, Small Interfering; Signal Transduction | 2014 |
Combined Strategies for Maintaining Skeletal Muscle Mass and Function in Aging: Myostatin Inactivation and AICAR-Associated Oxidative Metabolism Induction.
Topics: Aging; Aminoimidazole Carboxamide; Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; CD36 Antigens; Glucose Transporter Type 4; Hypertrophy; Hypoglycemic Agents; Male; Mice, Knockout; Microtubule-Associated Proteins; Mitochondria, Muscle; Muscle, Skeletal; Myostatin; Organ Size; Oxygen Consumption; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Conditioning, Animal; Physical Endurance; Ribonucleotides; RNA-Binding Proteins; Transcription Factors | 2015 |
Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Animals; Catalytic Domain; Cells, Cultured; Gene Expression Regulation, Enzymologic; Glucose; Hypertrophy; Hypoglycemic Agents; Mice; Models, Biological; Myocytes, Cardiac; Phosphorylation; Rats; Ribonucleotides | 2008 |
Antagonistic control of muscle cell size by AMPK and mTORC1.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Size; Food; Gene Knockout Techniques; Humans; Hypertrophy; Mechanistic Target of Rapamycin Complex 1; Mice; Motor Activity; Multiprotein Complexes; Muscle Development; Muscles; Protein Subunits; Proteins; Ribonucleotides; Signal Transduction; Sirolimus; Starvation; TOR Serine-Threonine Kinases | 2011 |
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Elongation Factor 2 Kinase; Enzyme Activation; Green Fluorescent Proteins; Hypertrophy; Hypoglycemic Agents; Immunoblotting; Luminescent Proteins; Metformin; Microscopy, Fluorescence; Multienzyme Complexes; Myocytes, Cardiac; Phenylephrine; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Ribonucleotides; Ribose; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Time Factors | 2004 |
AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
Topics: Acetyl-CoA Carboxylase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Electric Stimulation; Enzyme Activation; Enzyme Activators; Hypertrophy; Injections, Subcutaneous; Intracellular Signaling Peptides and Proteins; Male; Multienzyme Complexes; Muscle Contraction; Muscle, Skeletal; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred BN; Rats, Inbred F344; Ribonucleotides; Ribosomal Protein S6 Kinases; Sciatic Nerve; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases | 2008 |